Tegaserod Pellets

Tegaserod PelletsTegaserod is a 5-HT4 agonist manufactured by Novartis and sold under the name Zelnorm for the management of irritable bowel syndrome and constipation.

Approved by the FDA in 2002, it was subsequently removed from the market in 2007 due to FDA concerns about possible adverse cardiovascular effects.

Before then, it was the only drug approved by the United States Food and Drug Administration to help relieve the abdominal discomfort, bloating and constipation associated with irritable bowel syndrome.

Its use was also approved to treat chronic idiopathic constipation.

Available Form:
Tegaserod Pellets
Tegaserod Granules

Umang Pharmatech equipments used for production of Tegaserod Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Tegaserod Pellets
Systematic (IUPAC) Name
Tegaserod Pellets
Tegaserod Pellets
Chemical data
CAS number : 189188-57-6
ATC code : A03AE02
PubChem : CID 5362436
DrugBank :DB01079
ChemSpider : 10609889
UNII : 458VC51857
KEGG : D02730
Formula : C16H23N5O
Mol. mass : 301.39 g/mol

* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech